{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:03:55Z","timestamp":1794002635082,"version":"4.8.0"},"reference-count":20,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2009,7,16]],"date-time":"2009-07-16T00:00:00Z","timestamp":1247702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold>  <jats:italic>Babesia microti<\/jats:italic>, the primary cause of human babesiosis in the United States, is an intraerythrocytic parasite endemic to the Northeast and upper Midwest. Published studies indicate that <jats:italic>B. microti<\/jats:italic> increasingly poses a blood safety risk. The American Red Cross Hemovigilance Program herein describes the donor and recipient characteristics of suspected transfusion\u2010transmitted <jats:italic>B. microti<\/jats:italic> cases reported between 2005 and 2007.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> Suspected transfusion\u2010transmitted <jats:italic>Babesia<\/jats:italic> infections were reported by transfusion services or were discovered through recipient\u2010tracing investigations of prior donations from donors with a positive test for <jats:italic>B. microti<\/jats:italic> in a serologic study. Follow\u2010up samples from involved donors were tested by <jats:italic>Babesia<\/jats:italic>\u2010specific immunofluorescence assay, Western blot, and\/or real\u2010time polymerase chain reaction analysis.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> Eighteen definite or probable <jats:italic>B. microti<\/jats:italic> infections, including five fatalities, were identified in transfusion recipients, 16 from hospital\u2010reported cases and two through serologic lookback studies. Thirteen recipients were 61 to 84 years old and two were 2 years old or younger. Two recipients had sickle cell disease and four were known to be asplenic, including one with sickle cell disease. Seventeen antibody\u2010positive donors were implicated; 11 (65%) were residents in <jats:italic>Babesia<\/jats:italic>\u2010endemic areas, while four (24%) nonresident donors had a history of travel to endemic areas.<\/jats:p><jats:p><jats:bold>CONCLUSIONS:<\/jats:bold> Transfusion\u2010transmitted <jats:italic>B. microti<\/jats:italic> can be a significant cause of transfusion\u2010related morbidity and mortality, especially in infant, elderly, and asplenic blood recipients. These data demonstrate the need for interventions, in both endemic and nonendemic areas of the United States, to reduce patient risk.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2009.02317.x","type":"journal-article","created":{"date-parts":[[2009,7,17]],"date-time":"2009-07-17T04:49:36Z","timestamp":1247806176000},"page":"2557-2563","source":"Crossref","is-referenced-by-count":88,"title":["TRANSFUSION COMPLICATIONS: Transfusion\u2010transmitted <i>Babesia microti<\/i> identified through hemovigilance"],"prefix":"10.1111","volume":"49","author":[{"given":"Laura","family":"Tonnetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne F.","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Dy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Pisciotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Leiby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,12]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01811.x"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.13.3.451-469.2000"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807163390304"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1998.11813307"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/tmrv.2002.31462"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2006.00740.x"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/595010"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1991.31491213305.x"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-96-4-446"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01883.x"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.00609.x"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198011063031906"},{"key":"e_1_2_8_14_2","unstructured":"US Food and Drug Administration.FDA Workshop to Consider Approaches to Reduce the Risk of Transfusion\u2010Transmitted Babesiosis in the United States. [September 12 2008 Lister Hill Center Auditorium Building 38A National Institutes of Health 8800 Rockville Pike Bethesda MD 20894][cited 2009 June 22]. Available from:http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/NewsEvents\/WorkshopsMeetingsConferences\/TranscriptsMinutes\/UCM051501.pdf"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01762.x"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0901.020149"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40030274.x"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00251.x"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1089\/153036603765627451"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01418.x"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41050713.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2009.02317.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2009.02317.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T02:53:36Z","timestamp":1697252016000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2009.02317.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["10.1111\/j.1537-2995.2009.02317.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2009.02317.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}